abstract |
Formula (I): (I) Wherein Z is CH or N; W is CR 3 or N; and R 1 , R 2 and R 3 are as defined herein, or a pharmaceutical thereof Acceptable salts are disclosed. Also disclosed are methods of using such compounds in the treatment of at least one CYP17 related disease (eg, cancer, etc.) and pharmaceutical compositions comprising such compounds. |